Human virus causing respiratory tract infection and uses thereof
    2.
    发明授权
    Human virus causing respiratory tract infection and uses thereof 有权
    引起呼吸道感染的人类病毒及其用途

    公开(公告)号:US07553944B2

    公开(公告)日:2009-06-30

    申请号:US10895064

    申请日:2004-07-21

    摘要: The present invention provides the complete genomic sequence of a novel human coronavirus, coined as coronavirus-HKU1 (“CoV-HKU1”), isolated in Hong Kong from a patient who had a recent history of visit to Schenzhen, China. The virus belongs to the order Nidovirales of the family Coronaviridae, being a single-stranded RNA virus of positive polarity. The invention also provides the deduced amino acid sequences of the complete genome of the CoV-HKU1. The nucleotide sequences and deduced amino acid sequences of the CoV-HKU1 are useful in preventing, diagnosing and/or treating the infection by CoV-HKU1. Furthermore, the invention provides immunogenic and vaccine preparations using recombinant and chimeric forms as well as subunits of the CoV-HKU1 based on the nucleotide sequences and deduced amino acid sequences of the CoV-HKU1.

    摘要翻译: 本发明提供了一种新型人冠状病毒的完整基因组序列,其创造为冠状病毒HKU1(“CoV-HKU1”),在香港从最近访问中国的深圳的病人中分离出来。 该病毒属于冠状病毒科家族的Nidovirales,是正极性的单链RNA病毒。 本发明还提供了CoV-HKU1的完整基因组的推导的氨基酸序列。 CoV-HKU1的核苷酸序列和推导的氨基酸序列可用于预防,诊断和/或治疗CoV-HKU1感染。 此外,本发明基于CoV-HKU1的核苷酸序列和推定的氨基酸序列,提供使用重组和嵌合形式以及CoV-HKU1的亚基的免疫原性和疫苗制剂。

    Human virus causing respiratory tract infection and uses thereof
    3.
    发明授权
    Human virus causing respiratory tract infection and uses thereof 有权
    引起呼吸道感染的人类病毒及其用途

    公开(公告)号:US08092994B2

    公开(公告)日:2012-01-10

    申请号:US12476019

    申请日:2009-06-01

    IPC分类号: C12Q1/68

    摘要: The present invention provides the complete genomic sequence of a novel human coronavirus, coined as coronavirus-HKU1 (“CoV-HKU1”), isolated in Hong Kong from a patient who had a recent history of visit to Schenzhen, China. The virus belongs to the order Nidovirales of the family Coronavirdae, being a single-stranded RNA virus of positive polarity. The invention also provides the deduced amino acid sequences of the complete genome of the CoV-HKU1. The nucleotide sequences and deduced amino acid sequences of the CoV-HKU1 are useful in preventing, diagnosing and/or treating the infection by CoV-HKU1. Furthermore, the invention provides immunogenic and vaccine preparations using recombinant and chimeric forms as well as subunits of the CoV-HKU1 based on the nucleotide sequences and deduced amino acid sequences of the CoV-HKU1.

    摘要翻译: 本发明提供了一种新型人冠状病毒的完整基因组序列,其创造为冠状病毒HKU1(“CoV-HKU1”),在香港从最近访问中国的深圳的病人中分离出来。 该病毒属于Coronavirdae家族的Nidovirales,为正极性的单链RNA病毒。 本发明还提供了CoV-HKU1的完整基因组的推导的氨基酸序列。 CoV-HKU1的核苷酸序列和推导的氨基酸序列可用于预防,诊断和/或治疗CoV-HKU1感染。 此外,本发明基于CoV-HKU1的核苷酸序列和推定的氨基酸序列,提供使用重组和嵌合形式以及CoV-HKU1的亚基的免疫原性和疫苗制剂。

    High-Throughput Diagnostic Assay For the Human Virus Causing Severe Acute Respiratory Syndrome (SARS)
    6.
    发明申请
    High-Throughput Diagnostic Assay For the Human Virus Causing Severe Acute Respiratory Syndrome (SARS) 审中-公开
    用于严重急性呼吸综合征(SARS)的人类病毒的高通量诊断测定

    公开(公告)号:US20100285457A1

    公开(公告)日:2010-11-11

    申请号:US12483301

    申请日:2009-06-12

    IPC分类号: C12Q1/68

    摘要: The present invention relates to a high-throughput diagnostic assay for the virus causing Severe Acute Respiratory Syndrome (SARS) in humans (“hSARS virus”). In particular, the invention relates to a high-throughput reverse transcription-PCR diagnostic test for SARS associated coronavirus (SARS-CoV). The present assay is a rapid, reliable assay which can be used for diagnosis and monitoring the spread of SARS and is based on the nucleotide sequences of the N (nucleocapsid)-gene of the hSARS virus. The present method eliminates false negative results and provides increased sensitivity for the assay. The invention also discloses the S (spike)-gene of the hSARS virus. The invention further relates to the deduced amino acid sequences of the N-gene and S-gene products of the hSARS virus and to the use of the N-gene and S-gene products in diagnostic methods. The invention further encompasses diagnostic assays and kits comprising antibodies generated against the N-gene or S-gene product.

    摘要翻译: 本发明涉及用于引起人类严重急性呼吸综合征(SARS)的病毒(“hSARS病毒”)的高通量诊断测定。 特别地,本发明涉及SARS相关冠状病毒(SARS-CoV)的高通量逆转录PCR诊断试验。 本试验是一种快速,可靠的测定法,可用于诊断和监测SARS的扩散,并且基于hSARS病毒的N(核衣壳)基因的核苷酸序列。 本方法消除假阴性结果并提供增加的检测灵敏度。 本发明还公开了hSARS病毒的S(尖峰) - 基因。 本发明还涉及hSARS病毒的N-基因和S-基因产物的推断氨基酸序列以及在诊断方法中使用N-基因和S-基因产物。 本发明还包括诊断测定和试剂盒,其包含针对N-基因或S-基因产物产生的抗体。

    High-throughput diagnostic assay for the human virus causing severe acute respiratory syndrome (SARS)
    8.
    发明授权
    High-throughput diagnostic assay for the human virus causing severe acute respiratory syndrome (SARS) 有权
    导致严重急性呼吸综合征(SARS)的人类病毒的高通量诊断测定

    公开(公告)号:US07547512B2

    公开(公告)日:2009-06-16

    申请号:US10807807

    申请日:2004-03-24

    IPC分类号: C12Q1/68 C12Q1/00

    摘要: The present invention relates to a high-throughput diagnostic assay for the virus causing Severe Acute Respiratory Syndrome (SARS) in humans (“hSARS virus”). In particular, the invention relates to a high-throughput reverse transcription-PCR diagnostic test for SARS associated coronavirus (SARS-CoV). The present assay is a rapid, reliable assay which can be used for diagnosis and monitoring the spread of SARS and is based on the nucleotide sequences of the N (nucleocapsid)-gene of the hSARS virus. The present method eliminates false negative results and provides increased sensitivity for the assay. The invention also discloses the S (spike)-gene of the hSARS virus. The invention further relates to the deduced amino acid sequences of the N-gene and S-gene products of the hSARS virus and to the use of the N-gene and S-gene products in diagnostic methods. The invention further encompasses diagnostic assays and kits comprising antibodies generated against the N-gene or S-gene product.

    摘要翻译: 本发明涉及用于引起人类严重急性呼吸综合征(SARS)的病毒(“hSARS病毒”)的高通量诊断测定。 特别地,本发明涉及SARS相关冠状病毒(SARS-CoV)的高通量逆转录PCR诊断试验。 本试验是一种快速,可靠的测定法,可用于诊断和监测SARS的扩散,并且基于hSARS病毒的N(核衣壳)基因的核苷酸序列。 本方法消除假阴性结果并提供增加的检测灵敏度。 本发明还公开了hSARS病毒的S(尖峰)基因。 本发明还涉及hSARS病毒的N-基因和S-基因产物的推断氨基酸序列以及在诊断方法中使用N-基因和S-基因产物。 本发明还包括诊断测定和试剂盒,其包含针对N-基因或S-基因产物产生的抗体。